首页> 美国卫生研究院文献>other >Production of Inhalable Submicrometer Aerosols from Conventional Mesh Nebulizers for Improved Respiratory Drug Delivery
【2h】

Production of Inhalable Submicrometer Aerosols from Conventional Mesh Nebulizers for Improved Respiratory Drug Delivery

机译:生产来自常规网眼雾化器的可吸入潜膜气溶胶以改善呼吸药物递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Submicrometer and nanoparticle aerosols may significantly improve the delivery efficiency, dissolution characteristics, and bioavailability of inhaled pharmaceuticals. The objective of this study was to explore the formation of submicrometer and nanometer aerosols from mesh nebulizers suitable for respiratory drug delivery using experiments and computational fluid dynamics (CFD) modeling. Mesh nebulizers were coupled with add-on devices to promote aerosol drying and the formation of submicrometer particles, as well as to control the inhaled aerosol temperature and relative humidity. Cascade impaction experiments were used to determine the initial mass median aerodynamic diameters of 0.1% albuterol aerosols produced by the AeroNeb commercial (4.69 μm) and lab (3.90 μm) nebulizers and to validate the CFD model in terms of droplet evaporation. Through an appropriate selection of flow rates, nebulizers, and model drug concentrations, submicrometer and nanometer aerosols could be formed with the three devices considered. Based on CFD simulations, a wire heated design was shown to overheat the airstream producing unsafe conditions for inhalation if the aerosol was not uniformly distributed in the tube cross-section or if the nebulizer stopped producing droplets. In comparison, a counter-flow heated design provided sufficient thermal energy to produce submicrometer particles, but also automatically limited the maximum aerosol outlet temperature based on the physics of heat transfer. With the counter-flow design, submicrometer aerosols were produced at flow rates of 5, 15, and 30 LPM, which may be suitable for various forms of oral and nasal aerosol delivery. Thermodynamic conditions of the aerosol stream exiting the counter-flow design were found be in a range of 21-45 °C with relative humidity greater than 40% in some cases, which was considered safe for direct inhalation and advantageous for condensational growth delivery.
机译:潜膜和纳米粒子气溶胶可能显着提高吸入药物的输送效率,溶解特性和生物利用度。本研究的目的是探讨使用实验和计算流体动力学(CFD)建模的适用于呼吸药物递送的网眼雾化器的亚微米和纳米气溶胶的形成。网眼雾化器与附加装置相结合,以促进气溶胶干燥和形成潜力计颗粒,以及控制吸入的气溶胶温度和相对湿度。级联传输实验用于确定由Aeroneb商业(4.69μm)和实验室(3.90μm)雾化器产生的0.1%苯甲醇气溶胶的初始质量中值气动直径,并在液滴蒸发方面验证CFD模型。 Through an appropriate selection of flow rates, nebulizers, and model drug concentrations, submicrometer and nanometer aerosols could be formed with the three devices considered.基于CFD模拟,如果气溶胶在管横截面中或者雾化器停止产生液滴,则示出了一种导线加热设计,从而过热地产生不安全的吸入的不安全条件。相比之下,反流式加热设计提供了足够的热能来产生亚微米粒子,而且还根据热传递物理自动限制最大气溶胶出口温度。利用逆流设计,潜力计气溶胶以5,15和30Lpm的流速产生,这可能适用于各种形式的口腔和鼻气溶胶递送。在某些情况下,发现离开逆流设计的气溶胶流的热力学条件在21-45°C的范围内,相对湿度大于40%,这被认为是安全的直接吸入和有利的冷凝生长递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号